R&D Curia2311247033

06:00 PM CEST

Medicinal Chemistry Strategy Dinner

Our Agenda

Why you should attend

At Curia the journey to medical breakthrough may be linear, but it’s never simple. From discovery through manufacturing, launch through commercialization, we leverage deep scientific expertise and state-of-the-art technology to ensure every stage of this intricate process advances as quickly and accurately as possible.

Meet Our Facilitator

Christopher Conway

President, Research and Development Curia

Dr. Grant Carr

Vice President, Head of Global R&D Drug Discovery Curia

Douglas Kitchen

Research Fellow, Medicinal Chemistry Curia

Mark Wolf

Director, Medicinal Chemistry Curia

Matthew Surman

Associate Director, Medicinal Chemistry Curia

More about Curia

Curia is a Contract Research, Development and Manufacturing Organization with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecules offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state of the art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

    I agree to Proventa International storing this information to reply to my query and in accordance with our Privacy Policy.
    You may unsubscribe at any time.